Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;32(10):1825-1832.
doi: 10.1002/oby.24097. Epub 2024 Aug 1.

Utilization of antiobesity medications within the Military Health System

Taylor Neuman  1   2 , Richele Corrado  2   3 , Amanda Banaag  4   5 , Tracey Perez Koehlmoos  1   4
Affiliations

Utilization of antiobesity medications within the Military Health System

Taylor Neuman et al. Obesity (Silver Spring). 2024 Oct.

Abstract

Objective: The prevalence of overweight and obesity among beneficiaries of the Military Health System (MHS) is 41.6% and 30.5%, respectively. This incurs significant medical, fiscal, and military readiness costs. It is not currently known how the utilization of antiobesity medications (AOMs) within the MHS compares with that in the Veterans Health Administration or the private sector. Our aim was to assess the utilization of AOMs within the MHS.

Methods: A cross-sectional study was conducted using data gathered from the MHS Data Repository and the inclusion of all adult TRICARE Prime and Plus beneficiaries ages 18 to 64 years who were prescribed at least one TRICARE-approved AOM during the years 2018 to 2022.

Results: The total study population included 4,414,127 beneficiaries, of whom 1,871,780 were active-duty service members. The utilization of AOMs among the eligible population was 0.56% (0.44% among active-duty personnel). Liraglutide was the most-prescribed AOM (36% of the total). Female sex, age greater than or equal to 30 but less than 60 years, and enlisted or warrant officer rank were all associated with statistically significant higher odds of receiving AOMs.

Conclusions: Comparable with the US private sector, the MHS significantly underutilizes AOMs, including among active-duty service members, despite coverage of AOMs since 2018.

PubMed Disclaimer

References

REFERENCES

    1. Centers for Disease Control and Prevention, National Center for Health Statistics. Obesity and overweight. Updated January 5, 2023. https://www.cdc.gov/nchs/fastats/obesity-overweight.htm
    1. Rush T, LeardMann CA, Crum‐Cianflone NF. Obesity and associated adverse health outcomes among US military members and veterans: findings from the millennium cohort study. Obesity (Silver Spring). 2016;24(7):1582‐1589.
    1. Waters H, Graf M; Milken Institute. America's Obesity Crisis: the Health and Economic Costs of Excess Weight. Published October 2018. https://milkeninstitute.org/sites/default/files/reports‐pdf/Mi‐Americas‐...
    1. Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(suppl 3):1‐203.
    1. Bray GA, Kim KK, Wilding JPH. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;8(7):715‐723. doi:10.1111/obr.12551

MeSH terms

LinkOut - more resources